SUPERNUS PHARMACEUTICALS, INC. (SUPN) Form 8-K — Jul 22, 2026
Supernus Pharmaceuticals announced that it will report its second quarter 2026 financial results after the market closes on Tuesday, August 4, 2026. The press release confirms the date but does not contain actual performance data. The company will host a conference call and webcast on August 4, 2026, at 4:30 p.m. ET to discuss the results.
Price after filing
1 day: +0.5%7 days: -0.8%30 days: +1.1%
Close on the filing date to close N calendar days later (from $46.94). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.